Day one: Friday 4 March 2022

15:50 - 16:00

Opening Ceremony

Ashraf Dada, Fadi Alzayer & Ali Hajeer
ARSHI President

• SESSION 1

Stem Cell Transplantation (16:00-18:15)

• Chairpersons: Gehad El-Ghazali ( UAE), Dunia Jawdat (KSA), Jentsch Ute (South Africa)

16:00 - 16:30

Imunogenetics of Allogeneic stem cell Transplantation

Effie Wang Petersdorf

16:30 - 16:45

Discussion

16:45 - 16:55

The Clinical Relevance of Lymphocyte Subset-Counts to Transplant-Related GVHD after Allo-HSCT

Rabab Attas

16:55 - 17:05

Disparity rates of restricted expression minor histocompatibility antigens and their impact on Egyptian patients undergoing Hematopoietic stem cell transplantation

Maha Hosni

17:05 - 17:15

Rescue of a young patient with life threatening and therapy refractory thrombocytopenia using HLA matched platelet donor

Rayan Bawayan

17:15 - 17:30

Abstract Discussion

17:30 - 18:30

Prevention and Prediction of Leukemia Relapse after Allogeneic Hematopeitic Cell Transplantation

Faisal Khan

End of Day 1

Day two: Saturday 5 March 2022

• SESSION 1

Kidney Transplantation (8:00-10:15 AM)

• Chairpersons: Rabab Alattas (KSA ) & Khalid AL- Hassan(KSA), Heather Dunckley (New Zealand)

08:00 - :08:30

Histocompatibility Laboratories Supporting Deceased Donor Transplantation: Models & Best Practices

Medhat Askar  

08:30 - :08:45

Discussion

08:45 - :08:55

IMPACT of ABO INCOMPATIBILITY ON HLA FLOW CROSS-MATCH RESULTS IN ABO INCOMPATIBLE KIDNEY TRANSPLANTATION

Khalid El- Faki

08:55 - :09:05

Epitope Analysis and Titration Studies as Prognostic Tools for Desensitization in a Pediatric Kidney Patient with Multiple De

Ahmed Abu- Khader

09:05 - :09:15

6- Development of a CPRA Calculator for Sensitized Renal Transplant Waitlist Patients in the UAE

Mrs. Marion Al-vares

09:15 - :09:30

Abstract Discussion

09:30 - :10:00

History of Transplantation

Ahmed Mostafa

10:00 - :10:15

Discussion

10:15 - :10:30

Break

• SESSION 2

Immunogenetics (10:30 to 12:45)

• Chairpersons : Noureddine Berka (Canada) & Zein El-Yafie (UAE) Sally Elfishawi (Egypt)

10:30 - :11:00

Population Data From India

Narinder Mehra

11:00 - :11:15

Discussion

11:15 - :11:25

Human Leukocyte Antigen (HLA) Association and Anti-Cyclic Citrullinated Peptide (anti - CCP) Antibodies Status in Rheumatoid Arthritis : a Bahraini Tertiary Center Experience

Eman Farid

11:25 - :11:35

IL 12B rs 321327, IL 27 , rs 17855750 , and TNF α rs 1800629 and their expression in Egyptian patients with Bladder cancer

Mona El-Wassefy

11:35 - :11:45

Identification of novel pathogenic variant in PALB2 genes that associated with breast cancer in Saudi Population

Yousef M. Hawsawi

11:45 - :12:00

Abstract Discussion

12:00 - :12:30

COVID - 19 and KIR

Ali Hajeer

12:30 - :12:45

Discussion

12:45 - :14:00

Break

• SESSION 3

Covid 19 Update (14:00 to 16:15)

• Chairpersons: Rania Bakry ( Egypt), Moheeb Alawami (KSA) & Ghada Musallam (Eygpt)

14:00 - :14:30

Challenges faced in the hospital During COVID- 19 pandemic

Ghassan Wali

14:30 - :14:45

Discussion

14:45 - :14:55

THE IMMUNOGENCITIY OF SARS-CoV-2 VIRUS AND THE GENERATION OF HLA ANTIBODIES IN CONVALESCENT PLASMA DONORS

Khalid El- Faki

14:55 - :15:05

Immunogenetic Features in Health care workers with SARS-CoV-2 Breakthrough Infections Claudia Leman

Claudia Lehmann

15:05 - :15:15

T and B cells isolation using magnetic selection beads is associated with better cell yield and better outcome of flow cytometry crossmatch

Adil Lafi

15:15 - :15:30

Abstract Discussion

15:30 - :16:00

Accurate laboratory diagnosis and effective management of COVID-19

Ashraf Dada

16:00 - :16:15

Discussion

16:15 - :16:30

Break

• Experts Round

Future Technologies and Panel Disscussion (16:30 to 18:10)

• Chairpersons: Hatim Al-abbas (UAE) - Reem Jan ( Egypt) - Nada Al- Shatti (Kuwait) & Fadi Al- Zayer (KSA)

16:30 - :16:50

Artificial lntelligence and HLA Ab Analysis

Ilias Doxiadis

16:50 - :17:10

The HLA landscape of tumors and healthy tissue

William Hildebrand

17:10 - :17:30

HLA typing by Nanopore

Chang Liu

17:30 - :17:50

H&I Societies: future Challenges

Ann Margaret Little

17:50 - :18:10

Panel Discussion

18:10 - :18:25

Break

18:25 - :18:50

Official Transition

Old and New board members

Closing Remarks (18:50 - 19:00)

18:50 - :19:00

Ashraf Dada

19:00

End of the Conference